Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Healthcare Services
Hospital
30 Cr
Low Risk
-8.2
60.3
—
—
109.70
43.82
Sales CAGR
Profit CAGR
ROE
ROCE

Bearish
6
Neutral
4
Bullish
4
Bearish
11
Neutral
16
Bullish
19
Bearish
5
Neutral
12
Bullish
15
Bearish
5
Neutral
12
Bullish
15
Bearish
5
Neutral
12
Bullish
15
Bearish
5
Neutral
12
Bullish
15
Soni Medicare Ltd (SML) is currently trading at 69.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Soni Medicare Limited operates Soni Hospital, a NABH-accredited multi‑specialty hospital in Jaipur focused on inpatient and outpatient healthcare services, maternal and child health, and ancillary healthcare education through a Skill Institute; the company positions itself as a regional healthcare provider with historical roots dating to 1988 and a revamped women’s health centre called 'JOY'. The Q1 FY2027 unaudited results show revenue from operations declined to 455.27 (reported unit) versus 727.71 in the prior-year quarter, with total income at 477.84 and a reported net loss (comprehensive) around -119.85, producing a negative basic EPS of -2.81; these numbers signal acute margin pressure and weaker utilization or service volumes in the quarter. Management formally reassessed operating segments under Ind AS 108 and concluded the business reports as a single primary segment, 'Healthcare Facilities'; the Skill Institute was judged quantitatively immaterial for separate disclosure, highlighting the company’s current strategic emphasis on hospital operations and simplifying external reporting and investor focus on core facility performance. Governance and disclosure show timely compliance: the Board approved Q1 results on 14 August 2026 with a limited review by TamBi Ashok & Associates, and paid-up equity capital is disclosed at 426.49 (face value Rs.10), indicating capital base transparency while the audited/limited review outcomes contained no material exceptions in the auditor’s review report. Operational cost structure shows elevated employee and other operating expenses relative to revenue, and finance costs increased quarter-on-quarter, indicating leverage and cost absorption issues; historically the hospital underwent a major infrastructure revamp in 2020 to launch JOY, which provides a platform to deepen women's health services but requires higher utilization to restore margins.
Over the past 52 weeks, Soni Medicare Ltd has traded between a low of ₹43.82 and a high of ₹109.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Soni Medicare Ltd has a market capitalization of approximately 29.58. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Soni Medicare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -8.17 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 29.58 Cr, Soni Medicare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Soni Medicare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Soni Medicare Ltd is -8.17. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.